...Valeant will acquire aesthetic device company Solta for $2.92 per share in cash, or about $250... ...per share in cash, or about $250 million. The price is a 40% premium to Solta's... ...on Dec. 13, 2013, before the deal was disclosed. The deal has been approved by Solta's...
...based on regulatory milestones and year-to-year performance increases of the subsidiary's Liposonix fat ablation system. Solta... ...is approved in the U.S. Details were not disclosed. Medicis Pharmaceutical Corp. (NYSE:MRX), Scottsdale, Ariz. Solta Medical Inc....
...Valeant will acquire aesthetic device company Solta for $2.92 per share in cash, or about $250... ...per share in cash, or about $250 million. The price is a 40% premium to Solta's... ...on Dec. 13, 2013, before the deal was disclosed. The deal has been approved by Solta's...
...based on regulatory milestones and year-to-year performance increases of the subsidiary's Liposonix fat ablation system. Solta... ...is approved in the U.S. Details were not disclosed. Medicis Pharmaceutical Corp. (NYSE:MRX), Scottsdale, Ariz. Solta Medical Inc....